NO913524D0
(en )
1991-09-06
NUCLEOTID SEQUENCE CODING FOR AN OUTER MEMBRANE PROTEIN FRANEISSERIA MENINGITIDIS AND USE THEREOF.
BR9402659A
(en )
1995-04-04
Instrument, photoemitter, and photoemitter handling instrument.
EP0571442A4
(en )
1995-05-03
Cytokine-induced protein, tsg-14, dna coding therefor and uses thereof.
DK317288D0
(en )
1988-06-10
HUMAN PROTEIN C HYBRID PROTEIN AND ITS PREPARATION AND DNA CODING IT
NO306753B1
(en )
1999-12-20
Chair regulator
IL90209A0
(en )
1989-12-15
Dna coding for a hiv-1 protein,the protein produced and its use
NO308287B1
(en )
2000-08-28
Substituted 4-phenyl-6-amino-nicotinic acid derivatives, drugs containing them and their use
AU6550894A
(en )
1994-10-11
Human serotonin receptors, dna encoding the receptors, and uses thereof
DK639988D0
(en )
1988-11-16
PEPTIDES AND USE THEREOF.
TR199500915A2
(en )
1996-06-21
Peptides.
NO963487D0
(en )
1996-08-22
Isolated tyrosinase-derived peptides, and uses thereof
NO306060B1
(en )
1999-09-13
Substituted cinnamic acid guanides, their use, and drugs containing the guanides
FI894600A0
(en )
1989-09-28
NY SAMMANSAETTNING SOM INNEHAOLLER ISOCYANAT-REAKTIVA VAETE INNEHAOLLANDE FOERENINGAR.
BR9406536A
(en )
1996-01-02
DNA segment comprising gene encoding insecticidal protein
NO920500D0
(en )
1992-02-07
NUCLEOTIDE SEQUENCE CODING AN OUTER MEMBRANE PROTEIN FRANEISSERIA MENINGITIDIS AND USE THEREOF
NO911243D0
(en )
1991-03-26
CHEMICAL PREPARATIONS.
FI955902A0
(en )
1995-12-08
Telecommunication system, as well as the telecommunication switch and procedure
NO901758L
(en )
1990-10-23
PURE-INHIBITING DIPEPTIDES, THE PROCEDURE FOR THEIR PREPARATION, MENTALS CONTAINING THESE AND THEIR USE.
NL1001230C1
(en )
1996-03-21
Footrest.
NL1000434C2
(en )
1995-11-24
Acetylene copolymers and membranes thereof.
ES1029356Y
(en )
1995-11-01
BOTTLE FOR MULTIPLE USE.
IT1268116B1
(en )
1997-02-20
CHAIR.
IT8560494V0
(en )
1985-11-08
AND, FOR CHAIRS.
DK661389D0
(en )
1989-12-22
DNA SEQUENCE CODING PLACENT-SPECIFIC PROTEIN PP11, ITS ISOLATION AND USE
NO963917D0
(en )
1996-09-19
Isolated MAGE-3-Derived Peptides Complexing with HLA-A2 Molecules, and Uses thereof